<DOC>
	<DOCNO>NCT02739659</DOCNO>
	<brief_summary>The aim research project assess feasibility safety carbon-ion radiotherapy ( CIRT ) treatment Chinese localized prostate cancer</brief_summary>
	<brief_title>Carbon Ion Radiotherapy Treatment Localized Prostate Cancer</brief_title>
	<detailed_description>The purpose study determine maximal tolerate dose ( MTD ) CIRT treatment localized prostate cancer evaluate efficacy treatment MTD . Participants treat CIRT escalate dose regimen evaluate maximal tolerate dose ( MTD ) term acute subacute toxicity observe within 6 month completion CIRT . Once MTD localize prostate cancer determine , MTD use recommend dose patient fulfil inclusion criterion Phase II part trial .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Pathologically confirm adenocarcinoma prostate No lymph node distant metastasis Age ≥ 20 &lt; 85 year age Karnofsky Performance Score ≥70 No previous pelvic radiation therapy ( RT ) No previous prostatectomy No previous invasive cancer ( within 5 year prostate cancer diagnosis ) except skin nonmelanoma cancer Ability understand character individual consequence clinical trial Willing sign write informed consent ; Informed consent must sign enrollment trial No pathologically confirm adenocarcinoma prostate Pelvic lymph node metastasis ( N1 ) Distant metastasis ( M1 ) Urinary obstructive symptom ( IPSS &gt; 20 ) Previous pelvic radiotherapy Previous prostatectomy Severe systemic disorder Concomitant disorder include : chronic urinary intestinal inflammatory condition ( example , ulcerous rectocolitis , Crohn disease ) , anticoagulant treatment ( warfarin , heparin ) Previous malignancy except skin nonmelanoma cancer 3year disease free interval previous malignancy like non muscle invasive bladder cancer Non conformity radiotherapy dose distribution compare dose constraint Psychiatric disorder condition make unreliable informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>prostate carcinoma</keyword>
	<keyword>carbon-ion radiotherapy</keyword>
	<keyword>efficacy</keyword>
	<keyword>toxicity</keyword>
</DOC>